Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.

Reyes J, Komarow L, Chen L, Ge L, Hanson BM, Cober E, Herc E, Alenazi T, Kaye KS, Garcia-Diaz J, Li L, Kanj SS, Liu Z, Oñate JM, Salata RA, Marimuthu K, Gao H, Zong Z, Valderrama-Beltrán SL, Yu Y, Tambyah P, Weston G, Salcedo S, Abbo LM, Xie Q, Ordoñez K, Wang M, Stryjewski ME, Munita JM, Paterson DL, Evans S, Hill C, Baum K, Bonomo RA, Kreiswirth BN, Villegas MV, Patel R, Arias CA, Chambers HF, Fowler VG Jr, Doi Y, van Duin D, Satlin MJ, Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators

Open source

DOI
10.1016/s2666-5247(22)00329-9
Published
2023 Mar
Container
The Lancet. Microbe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2666-5247-22-00329-9,
  title = {Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.},
  author = {Reyes J and Komarow L and Chen L and Ge L and Hanson BM and Cober E and Herc E and Alenazi T and Kaye KS and Garcia-Diaz J and Li L and Kanj SS and Liu Z and Oñate JM and Salata RA and Marimuthu K and Gao H and Zong Z and Valderrama-Beltrán SL and Yu Y and Tambyah P and Weston G and Salcedo S and Abbo LM and Xie Q and Ordoñez K and Wang M and Stryjewski ME and Munita JM and Paterson DL and Evans S and Hill C and Baum K and Bonomo RA and Kreiswirth BN and Villegas MV and Patel R and Arias CA and Chambers HF and Fowler VG Jr and Doi Y and van Duin D and Satlin MJ and Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators},
  year = {2023},
  journal = {The Lancet. Microbe},
  doi = {10.1016/s2666-5247(22)00329-9},
  url = {https://doi.org/10.1016/s2666-5247(22)00329-9}
}

RIS

TY  - JOUR
TI  - Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
AU  - Reyes J
AU  - Komarow L
AU  - Chen L
AU  - Ge L
AU  - Hanson BM
AU  - Cober E
AU  - Herc E
AU  - Alenazi T
AU  - Kaye KS
AU  - Garcia-Diaz J
AU  - Li L
AU  - Kanj SS
AU  - Liu Z
AU  - Oñate JM
AU  - Salata RA
AU  - Marimuthu K
AU  - Gao H
AU  - Zong Z
AU  - Valderrama-Beltrán SL
AU  - Yu Y
AU  - Tambyah P
AU  - Weston G
AU  - Salcedo S
AU  - Abbo LM
AU  - Xie Q
AU  - Ordoñez K
AU  - Wang M
AU  - Stryjewski ME
AU  - Munita JM
AU  - Paterson DL
AU  - Evans S
AU  - Hill C
AU  - Baum K
AU  - Bonomo RA
AU  - Kreiswirth BN
AU  - Villegas MV
AU  - Patel R
AU  - Arias CA
AU  - Chambers HF
AU  - Fowler VG Jr
AU  - Doi Y
AU  - van Duin D
AU  - Satlin MJ
AU  - Antibacterial Resistance Leadership Group and Multi-Drug Resistant Organism Network Investigators
PY  - 2023
JO  - The Lancet. Microbe
DO  - 10.1016/s2666-5247(22)00329-9
UR  - https://doi.org/10.1016/s2666-5247(22)00329-9
ER  -

APA

J, R., L, K., L, C., L, G., BM, H., E, C., E, H., T, A., KS, K., J, G., L, L., SS, K., Z, L., JM, O., RA, S., K, M., H, G., Z, Z., SL, V., Y, Y., P, T., G, W., S, S., LM, A., Q, X., K, O., M, W., ME, S., JM, M., DL, P., S, E., C, H., K, B., RA, B., BN, K., MV, V., R, P., CA, A., HF, C., Jr, F. V., Y, D., D, V. D., MJ, S., & Investigators, A. R. L. G. A. M. R. O. N. (2023). Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.. The Lancet. Microbe. https://doi.org/10.1016/s2666-5247(22)00329-9

Source records